<DOC>
	<DOCNO>NCT01284777</DOCNO>
	<brief_summary>Accurate characterization malignant cell obtain via thoracocentesis paramount importance management cancer patient . The identification novel biomarkers may regard considerably improve diagnostic approach pleural effusion , guide therapeutic decision , particularly respect target therapy , offer helpful prognostic information . Nuclear anomaly represent cornerstone cytologic and/or histopathologic diagnosis malignant cell . The nuclear matrix fundamental constituent nuclear architecture via interaction nuclear membrane , also directly involve DNA RNA processing . Prior study suggest cancer , lamins , major constituent nuclear matrix , different pattern expression nuclear localization could potentially prognostic implication . Our project aim study constituent nuclear matrix malignant cell isolated pleural fluid patient metastatic disease , bronchogenic non-bronchogenic origin , , knowledge , yet do . Both proteomic ( localization immunofluorescence expression Western-Blot ) genomic ( microarray , CGH type ) analyse undertaken identify microrearrangements gene interest . The primary aim identify specific biomarkers accurately characterize malignant cell metastatic pleural disease .</brief_summary>
	<brief_title>Nuclear Matrix Cancer : Proteomic Genomic Analyses Using Microarray Cells Obtained Via Thoracocentesis</brief_title>
	<detailed_description />
	<criteria>sign consent approval patient metastatic disease , bronchogenic nonbronchogenic origin 50 % malignant cell patient tumoral treatment thoracocentesis 50 % less malignant cell</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>cancerology</keyword>
	<keyword>genetic</keyword>
</DOC>